Want to see RGNX full AI Analyst Report?
RegenXBio (RGNX) Ownership - Who Owns RegenXBio?
RegenXBio (RGNX) Ownership Overview
- 7.10% Insiders
- 13.66% Mutual Funds
- 0.33% Other Institutional Investors
- 14.94% ETFs
- 63.97% Public Companies and Individual Investors
The ownership structure of RegenXBio (RGNX) stock is a mix of institutional, retail, and individual investors. Approximately 28.94% of the company’s stock is owned by Institutional Investors, 7.10% is owned by Insiders, and 63.97% is owned by Public Companies and Individual Investors.
The ownership structure of RegenXBio (RGNX) stock is a mix of institutional, retail, and individual investors. Approximately 13.99% of the company’s stock is owned by Institutional Investors, 7.10% is owned by Insiders, and 14.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 26, 2026 | Gregory Austin Ciongoli | $949,007 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 3,049,451 | Institution | 4.62% | 21,956,047 |
| Allan M. Fox | 2,911,327 | Insider | 4.41% | 20,961,554 |
| Ishares | 2,890,382 | Institution | 4.38% | 20,810,750 |
| Spdr | 2,258,649 | Institution | 3.42% | 16,262,273 |
| Vanguard Index Funds | 2,060,615 | Institution | 3.12% | 14,836,428 |
| Tiaa-cref Funds | 1,030,643 | Institution | 1.56% | 7,420,630 |
| Blackrock Funds | 840,896 | Institution | 1.27% | 6,054,451 |
| Jpmorgan Trust Ii | 797,840 | Institution | 1.21% | 5,744,448 |
| Fidelity Salem Street Trust | 584,349 | Institution | 0.89% | 4,207,313 |
| Kenneth T. Mills | 495,925 | Insider | 0.75% | 3,570,660 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,060,615 | Institution | 3.12% | 14,836,428 |
| Tiaa-cref Funds | 1,030,643 | Institution | 1.56% | 7,420,630 |
| Blackrock Funds | 840,896 | Institution | 1.27% | 6,054,451 |
| Jpmorgan Trust Ii | 797,840 | Institution | 1.21% | 5,744,448 |
| Fidelity Salem Street Trust | 584,349 | Institution | 0.89% | 4,207,313 |
| Vanguard Horizon Funds | 467,248 | Institution | 0.71% | 3,364,186 |
| Fidelity Concord Street Trust | 449,454 | Institution | 0.68% | 3,236,069 |
| Delaware Group Equity Funds Iv | 447,000 | Institution | 0.68% | 3,218,400 |
| Vanguard Scottsdale Funds | 331,543 | Institution | 0.50% | 2,387,110 |
| Jpmorgan Trust I | 311,819 | Institution | 0.47% | 2,245,097 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| SPDR | 2,070,301 | Institution | 3.14% | 15,340,930 |
| Vanguard | 1,765,239 | Institution | 2.67% | 13,292,250 |
| iShares | 1,534,863 | Institution | 2.33% | 11,373,335 |
| Vanguard | 705,822 | Institution | 1.07% | 5,314,840 |
| Fidelity | 485,989 | Institution | 0.74% | 3,601,178 |
| iShares | 476,460 | Institution | 0.72% | 3,430,512 |
| iShares | 464,197 | Institution | 0.70% | 3,342,218 |
| Vanguard | 344,210 | Institution | 0.52% | 2,591,901 |
| Schwab | 323,194 | Institution | 0.49% | 2,394,868 |
| Vanguard | 165,003 | Institution | 0.25% | 1,242,473 |
FAQ
Who Owns RegenXBio (RGNX)?
According to the latest TipRanks data, approximately 0.33% of the company's stock is held by institutional investors, 7.10% is held by insiders, and 63.97% is held by retail investors.
What percentage of RegenXBio (RGNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.33% of RegenXBio (RGNX) stock is held by institutional investors.
What percentage of RegenXBio (RGNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.97% of RegenXBio (RGNX) stock is held by retail investors.
Who owns the most shares of RegenXBio (RGNX)?
Vanguard owns the most shares of RegenXBio (RGNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.